Trauma, chronic tissue damage, and late-stage cancer diagnosis remain major clinical challenges, largely due to the absence of biomaterials that can simultaneously provide mechanical adaptability, biological compatibility, and minimally invasive deployment. Conventional approaches often rely on chemistry-driven functionality or rigid device architectures, which can limit performance across diverse biomedical contexts. This dissertation presents a unified materials platform based on hybrid fibrou
